Income Statement (TTM)
Gemina Laboratories Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 10-31 |
2022 10-31 |
2025 04-30 |
|
|---|---|---|---|
| Revenue | 0 | -0 | 0 |
| Change (%) | -200.00 | -299.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | |||
| Change (%) | |||
| % of Revenue | |||
| Gross Operating Profit | 0 | -0 | 0 |
| Change (%) | -200.00 | -299.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 |
| SG&A | 2 | 2 | 2 |
| Change (%) | 17.58 | 39.43 | |
| % of Revenue | 28,016.19 | -32,941.65 | 22,981.35 |
| R&D | 2 | 3 | 1 |
| Change (%) | 47.77 | -61.99 | |
| % of Revenue | 43,369.36 | -64,085.84 | 12,188.70 |
| OpEx | 4 | 5 | 4 |
| Change (%) | 37.03 | -28.14 | |
| % of Revenue | 71,385.54 | -97,818.00 | 35,170.05 |
| Operating Income | -4 | -5 | -4 |
| Change (%) | 37.36 | -28.42 | |
| % of Revenue | -71,285.54 | 97,918.00 | -35,070.05 |
| Interest Expense | -0 | -0 | -0 |
| Change (%) | -62.80 | 18,372.45 | |
| % of Revenue | -44.99 | 16.74 | -1,547.01 |
| Net Income | -4 | -5 | -4 |
| Change (%) | 23.34 | -24.79 | |
| % of Revenue | -79,400.55 | 97,934.74 | -36,856.52 |
Source: Capital IQ
